These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 4430570)

  • 1. Negative findings with nicotinic acid in the treatment of schizophrenias.
    Ban TA
    Int Pharmacopsychiatry; 1974; 9(3):172-87. PubMed ID: 4430570
    [No Abstract]   [Full Text] [Related]  

  • 2. Nicotinic acid in the treatment of schizophrenias. Practical and theoretical considerations.
    Ban TA
    Neuropsychobiology; 1975; 1(3):133-45. PubMed ID: 8743
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Potentiation of therapeutic effects of nicotinic acid by pyridoxine in chronic schizophrenics.
    Ananth JV; Ban TA; Lehmann HE
    Can Psychiatr Assoc J; 1973 Oct; 18(5):377-83. PubMed ID: 4147710
    [No Abstract]   [Full Text] [Related]  

  • 4. On-going national collaborative studies in Canada: niacin in the treatment of schizophrenias.
    Ban TA
    Psychopharmacol Bull; 1969 Jul; 5(3):5-20. PubMed ID: 4906584
    [No Abstract]   [Full Text] [Related]  

  • 5. The use of nicotinic acid and pyridoxine in the treatment of schizophrenia.
    Petrie WM; Ban TA; Ananth JV
    Int Pharmacopsychiatry; 1981; 16(4):245-50. PubMed ID: 7040274
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nicotinic acid in the treatment of schizophrenias. Canadian Mental Health Association collaborative study: progress report II.
    Ban TA; Lehmann HE
    Can Psychiatr Assoc J; 1975 Mar; 20(2):103-12. PubMed ID: 1100217
    [No Abstract]   [Full Text] [Related]  

  • 7. Nicotinic acid and catechol-O-methyl-transferase activity in schizophrenia.
    Ban TA; Lehmann HE; Klingner A
    Int J Clin Pharmacol; 1973 Feb; 7(1):44-7. PubMed ID: 4699383
    [No Abstract]   [Full Text] [Related]  

  • 8. Biochemistry and schizophrenia III. A review of childhood psychosis.
    Guthrie RD; Wyatt RJ
    Schizophr Bull; 1975; (12):18-32. PubMed ID: 1101373
    [No Abstract]   [Full Text] [Related]  

  • 9. [Biochemical aspects of psychic disorders].
    Nalbandian RM
    Vopr Biokhim Mozga; 1972; 7(0):221-32. PubMed ID: 4607707
    [No Abstract]   [Full Text] [Related]  

  • 10. Nicotinic acid in the treatment of schizophrenia.
    Med Lett Drugs Ther; 1973 Dec; 15(26):107-8. PubMed ID: 4271841
    [No Abstract]   [Full Text] [Related]  

  • 11. A review of nicotinic acid, N-methylated indoleamines and schizophrenia.
    Luchins D; Ban TA; Lehmann HE
    Int Pharmacopsychiatry; 1978; 13(1):16-33. PubMed ID: 342436
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transmethylation hypothesis of schizophrenia: methionine and nicotinic acid.
    Nestoros JN; Ban TA; Lehmann HE
    Int Pharmacopsychiatry; 1977; 12(4):215-46. PubMed ID: 338534
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A review of recent studies of the biosynthesis and excretion of hallucinogens formed by methylation of neurotransmitters or related substances.
    Rosengarten H; Friedhoff AJ
    Schizophr Bull; 1976; 2(1):90-105. PubMed ID: 779022
    [No Abstract]   [Full Text] [Related]  

  • 14. [Biochemical treatment possibilities in psychoses].
    Kanig K; Oesterle W
    Med Welt; 1969 Sep; 36():1938-45. PubMed ID: 4241466
    [No Abstract]   [Full Text] [Related]  

  • 15. [Urinary excretion of bufotenin, N,N-dimethyltryptamine and 3,4-dimethoxyphenylethylamine and the clinical picture of mental disorders].
    Matsumoto H; Pietruszewska I
    Psychiatr Pol; 1978; 12(2):189-97. PubMed ID: 275869
    [No Abstract]   [Full Text] [Related]  

  • 16. Nicotinic acid and nicotinamide adenine dinucleotide (NAD) therapy in schizophrenia: a review.
    Wittkopp TA; Abuzzahab FS
    Behav Neuropsychiatry; 1972; 4(7-8):6-12. PubMed ID: 4348727
    [No Abstract]   [Full Text] [Related]  

  • 17. Nicotinic acid in the prevention and treatment of methionine-induced exacerbation of psychopathology in schizophrenics.
    Ananth JV; Ban TA; Lehmann HE; Bennett J
    Can Psychiatr Assoc J; 1970 Feb; 15(1):15-20. PubMed ID: 4906138
    [No Abstract]   [Full Text] [Related]  

  • 18. Pigmented hyperkeratosis among schizophrenic patients treated with nicotinic acid.
    Wittenborn JR; Nenno R; Rothberg H; Shelley WB
    Adv Biochem Psychopharmacol; 1974; 9(0):295-300. PubMed ID: 4151765
    [No Abstract]   [Full Text] [Related]  

  • 19. Megavitamin B-3 therapy for schizophrenia.
    Hoffer A
    Can Psychiatr Assoc J; 1971 Dec; 16(6):499-504. PubMed ID: 4947171
    [No Abstract]   [Full Text] [Related]  

  • 20. Nicotinic acid in the treatment of schizophrenias.
    Ban TA; Lehmann HE
    Can Psychiatr Assoc J; 1970 Oct; 15(5):499-500. PubMed ID: 5492190
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.